Knome
Human genome interpretation software and services for researchers investigating the genetic basis of rare diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€47—71m (Dealroom.co estimates Jan 2014.)
Cambridge Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $5.0m | Series A | |
| N/A | $5.0m | Series B | |
| N/A | $5.8m | Series C | |
| N/A | $13.0m | Series D | |
N/A | Acquisition | ||
| Total Funding | €26.2m | ||